Correlation Between Bank Mandiri and Pharma Bio
Can any of the company-specific risk be diversified away by investing in both Bank Mandiri and Pharma Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank Mandiri and Pharma Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank Mandiri Persero and Pharma Bio Serv, you can compare the effects of market volatilities on Bank Mandiri and Pharma Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank Mandiri with a short position of Pharma Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank Mandiri and Pharma Bio.
Diversification Opportunities for Bank Mandiri and Pharma Bio
0.78 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Bank and Pharma is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Bank Mandiri Persero and Pharma Bio Serv in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharma Bio Serv and Bank Mandiri is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank Mandiri Persero are associated (or correlated) with Pharma Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharma Bio Serv has no effect on the direction of Bank Mandiri i.e., Bank Mandiri and Pharma Bio go up and down completely randomly.
Pair Corralation between Bank Mandiri and Pharma Bio
Assuming the 90 days horizon Bank Mandiri Persero is expected to under-perform the Pharma Bio. But the pink sheet apears to be less risky and, when comparing its historical volatility, Bank Mandiri Persero is 3.43 times less risky than Pharma Bio. The pink sheet trades about -0.18 of its potential returns per unit of risk. The Pharma Bio Serv is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 63.00 in Pharma Bio Serv on September 16, 2024 and sell it today you would lose (8.00) from holding Pharma Bio Serv or give up 12.7% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Bank Mandiri Persero vs. Pharma Bio Serv
Performance |
Timeline |
Bank Mandiri Persero |
Pharma Bio Serv |
Bank Mandiri and Pharma Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bank Mandiri and Pharma Bio
The main advantage of trading using opposite Bank Mandiri and Pharma Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank Mandiri position performs unexpectedly, Pharma Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharma Bio will offset losses from the drop in Pharma Bio's long position.Bank Mandiri vs. Morningstar Unconstrained Allocation | Bank Mandiri vs. Bondbloxx ETF Trust | Bank Mandiri vs. Spring Valley Acquisition | Bank Mandiri vs. Bondbloxx ETF Trust |
Pharma Bio vs. Grey Cloak Tech | Pharma Bio vs. CuraScientific Corp | Pharma Bio vs. Love Hemp Group | Pharma Bio vs. Greater Cannabis |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |